Switch theme
Sign up to access all valuation multiples
Ems-Chemie Holding AG is a holding company, which, through its subsidiaries, manufactures and sells a variety of chemical-based products. The firm organizes itself into two segments based on product type: High-Performance Polymers and Specialty Chemicals. The High-Performance Polymers segment, which generates the majority of revenue, sells plastic products to the automotive, electrical, and electronics industries. The Specialty Chemicals segment sells fibres, bonding agents for tires, and fusible bonding yarns for textiles and powder coating products. Geographically, the majority of its revenue comes from Europe and the rest from Asia, the Americas, and other regions.
1962
2.7K+
LTM Revenue $2.5B
LTM EBITDA $718M
$16.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ems-Chemie has a last 12-month revenue (LTM) of $2.5B and a last 12-month EBITDA of $718M.
In the most recent fiscal year, Ems-Chemie achieved revenue of $2.5B and an EBITDA of $724M.
Ems-Chemie expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ems-Chemie valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | XXX | $2.5B | XXX | XXX | XXX |
| Gross Profit | $1.0B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Margin | 41% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | $718M | XXX | $724M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBIT | $654M | XXX | $648M | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | 26% | XXX | XXX | XXX |
| Net Profit | $561M | XXX | $553M | XXX | XXX | XXX |
| Net Margin | 23% | XXX | 22% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ems-Chemie's stock price is CHF 625 (or $750).
Ems-Chemie has current market cap of CHF 14.6B (or $17.6B), and EV of CHF 14.1B (or $16.9B).
See Ems-Chemie trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16.9B | $17.6B | XXX | XXX | XXX | XXX | $23.84 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ems-Chemie has market cap of $17.6B and EV of $16.9B.
Ems-Chemie's trades at 6.8x EV/Revenue multiple, and 23.4x EV/EBITDA.
Equity research analysts estimate Ems-Chemie's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ems-Chemie has a P/E ratio of 31.3x.
See valuation multiples for Ems-Chemie and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17.6B | XXX | $17.6B | XXX | XXX | XXX |
| EV (current) | $16.9B | XXX | $16.9B | XXX | XXX | XXX |
| EV/Revenue | 6.9x | XXX | 6.8x | XXX | XXX | XXX |
| EV/EBITDA | 23.6x | XXX | 23.4x | XXX | XXX | XXX |
| EV/EBIT | 25.9x | XXX | 26.1x | XXX | XXX | XXX |
| EV/Gross Profit | 16.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 31.3x | XXX | 31.7x | XXX | XXX | XXX |
| EV/FCF | 27.4x | XXX | 31.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEms-Chemie's last 12 month revenue growth is 1%
Ems-Chemie's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.
Ems-Chemie's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ems-Chemie's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ems-Chemie and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | 26% | XXX | 30% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ems-Chemie acquired XXX companies to date.
Last acquisition by Ems-Chemie was XXXXXXXX, XXXXX XXXXX XXXXXX . Ems-Chemie acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ems-Chemie founded? | Ems-Chemie was founded in 1962. |
| Where is Ems-Chemie headquartered? | Ems-Chemie is headquartered in Switzerland. |
| How many employees does Ems-Chemie have? | As of today, Ems-Chemie has 2.7K+ employees. |
| Who is the CEO of Ems-Chemie? | Ems-Chemie's CEO is Ms. Magdalena Martullo. |
| Is Ems-Chemie publicy listed? | Yes, Ems-Chemie is a public company listed on SWX. |
| What is the stock symbol of Ems-Chemie? | Ems-Chemie trades under EMSN ticker. |
| When did Ems-Chemie go public? | Ems-Chemie went public in 2010. |
| Who are competitors of Ems-Chemie? | Similar companies to Ems-Chemie include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of Ems-Chemie? | Ems-Chemie's current market cap is $17.6B |
| What is the current revenue of Ems-Chemie? | Ems-Chemie's last 12 months revenue is $2.5B. |
| What is the current revenue growth of Ems-Chemie? | Ems-Chemie revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Ems-Chemie? | Current revenue multiple of Ems-Chemie is 6.9x. |
| Is Ems-Chemie profitable? | Yes, Ems-Chemie is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ems-Chemie? | Ems-Chemie's last 12 months EBITDA is $718M. |
| What is Ems-Chemie's EBITDA margin? | Ems-Chemie's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Ems-Chemie? | Current EBITDA multiple of Ems-Chemie is 23.6x. |
| What is the current FCF of Ems-Chemie? | Ems-Chemie's last 12 months FCF is $618M. |
| What is Ems-Chemie's FCF margin? | Ems-Chemie's last 12 months FCF margin is 25%. |
| What is the current EV/FCF multiple of Ems-Chemie? | Current FCF multiple of Ems-Chemie is 27.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
